The HBSAg Card test is highly accurate in detecting Hepatitis B surface antigen in the blood.

Yes, patient confidentiality is strictly maintained during HBSAg testing, and results are handled discreetly by trained healthcare professionals.

No, additional tests may be required to differentiate between acute (recently acquired) and chronic (long-term) Hepatitis B infection.

The test can detect Hepatitis B surface antigen early in the course of infection, typically within a few weeks after exposure.

A positive result requires further confirmation with additional tests. Counseling and appropriate medical care will be provided to manage Hepatitis B infection effectively.

The test measures the concentration of potassium in the blood to assess overall potassium status.

No, fasting is not typically required for this test.

Causes include inadequate dietary intake, excessive losses (e.g., through vomiting or diarrhea), or certain medications.

Yes, high levels can be life-threatening, requiring immediate medical attention and treatment.

A blood sample is taken from a vein, usually in the arm, and analyzed in a laboratory.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.